MIRA INFORM REPORT

 

 

Report Date :

09.05.2007

 

IDENTIFICATION DETAILS

 

Name :

MEDICAL BIOMATERIAL AND PHARMACEUTICAL COMPANY LIMITED

 

 

Registered Office :

No.25-31 Ngo Thoi Nhiem Str, Dist 3, Hochiminh City

 

 

Country :

Vietnam

 

 

Financials (as on) :

31.12.2005

 

 

Date of Incorporation :

1993

 

 

Legal Form :

One Member Liability Limited Company (State Owned)

 

 

Line of Business :

Production and trading in health threads, pharmaceutical products and other special biopharmaceutical products.

Import materials, equipment specialized for pharmaceutical production; trading on medical biological products; packaging and medical cleaning services;

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 


 

SUBJECT INDENTIFICATION & LEGAL FORM

 

New English Name
 
MEDICAL BIOMATERIAL AND PHARMACEUTICAL COMPANY LIMITED
New Vietnamese Name
 
CONG TY TNHH MOT THANH VIEN DUOC PHAM VA SINH HOC Y TE
Trade Name
 
MEBIPHAR
Former English Name
 
MEDICAL BIOMATERIAL & PHARMACEUTICAL FACTORY

Former Vietnamese name

 

XI NGHIEP DUOC PHAM SINH HOC Y TE

Current Type of Business

 

One Member Liability Limited Company (State Owned)

Former Type of Business

 

State Owned enterprise

Founded

 

1993

Establishment Decision

 

No.105/QD-UB

Date of decision

 

March 22nd 1993

Place of decision

 

People’s Committee of Hochiminh City

Re-organized

 

March 07th, 2007

New Business Registration

 

No.4104000565

Date of Issuance

 

March 07th, 2007

Place of Issuance

 

Business Registration Office of Hochiminh City

Former Business Registration

 

No.4106000271

Date of Issuance

 

August 22nd, 2006

Original Business registration

 

No.102484

Date of Issuance

 

March 27th 1993

Place of Issuance

 

Hochiminh City department of planning & investment

New Registered Capital

 

36,000,000,000 VND

Former Registered Capital

 

 2,052,000,000 VND

Total Employees

 

400 employees (Including Staffs, Workers & Sales)

Qualification

 

Fairly good

 

 

ADDRESSES

 

Head Office and Factory

Address

 

No.25-31 Ngo Thoi Nhiem Str, Dist 3, Hochiminh City

Country

 

Vietnam

Tel

 

(84-8) 9303894 / 8299 894

Fax

 

(84-8) 9303109

Email

 

Mebiphar@saigonnet.vn

 

Factory’s Location

Address

 

Lot 3-18, Road No.13, Tan Binh Industrial Zone, Tay Thanh Ward, Tan Phu Dist, Hochiminh City

Country

 

Vietnam

Tel

 

(84-8) 8156103

Fax

 

(84-8) 8155683

 

Hanoi Branch

Address

 

66, C9, 148 Giang Vo Str, Hanoi City

Former Address

 

No.7–Ngoc Khanh Str, Hanoi City

Tel

 

(84-4) 7 721 044

Contact person

 

Mr. DAO XUAN SON

Position

 

Chief of Hanoi office

 

 

DIRECTORS

 

1. NAME

 

Mr. NGUYEN VAN SON

Position

 

Director

Qualification

 

Pharmacist, Management

Current resident

 

Hochiminh City-Vietnam

Nationality

 

Vietnamese

 

2. NAME

 

Mr. TRUONG TRONG TUAN

Position

 

Deputy director

Qualification

 

Pharmacist

Resident

 

Hochiminh City

Contact phone No.

 

(84-8) 9301143

Cell phone

 

+84 913927345

 

3. NAME

 

Mrs. TRAN THI HOI

Position

 

Former Director

Original resident

 

Hai Duong province (North of Vietnam)

Current resident

 

Hochiminh City

Nationality

 

Vietnamese

Note

 

She has retired in few years ago.

 

 

BUSINESS NATURE AND ACTIVITIES

 

The subject is specializing in following activities:

·         Production and trading in health threads, pharmaceutical products and other special biopharmaceutical products.

·         Import materials, equipment specialized for pharmaceutical production; trading on medical biological products; packaging and medical cleaning services;

·         Production and trading pharmaceutical products under the licence of foreign pharma companies such as: Tenamid of Canada. 

 

 

IMPORT & EXPORT ACTIVITIES

 

IMPORT: The subject imports materials, especially biomaterial for pharmaceutical production; It imports equipments, instruments for its factory (The subject is building a very big Production factory under GMP standard). It imports materials and equipment from EU, Singapore, Canada.

 

EXPORT: The subject’s products are mainly supplied for domestic.

 

 

BANKERS

 

1. BANK FOR INVESTMENT & DEVELOPMENT OF VIETNAM- HCM CITY BRANCH No 2

Address

 

No. 117, Nguyen Hue Str, Ben Nghe Ward, Dist 1, Hochiminh City

Country

 

Vietnam

Tel

 

(84-8) 9141729 - 8214924

Fax

 

(84-8) 9141979

Swift

 

BIDVVNVX310

 

2. VIETINDEBANK (HOCHIMINH CITY BRANCH)

Address

 

No.134 Nguyen Cong Tru, Dist 1, Hochiminh City

Tel

 

(84-8) 8216 827

Fax

 

(84-8) 829 8862

Contact Person

 

Mr. Tran Van Vinh

Position

 

Position

 

3. VIETNAM AGRICULTURAL & RURAL DEV. BANK (VBARD)

Address

 

No.2 Vo Van Ngan Str, Linh Chieu Ward, Thu Duc Dist, Hochiminh City

Tel

 

(84-8) 8963096

Contact person

 

Mr. Nguyen Quan

Position

 

Director

 

 

SHAREHOLDERS (S)

 

The subject is One Member Liability Limited Company (state owned enterprise. 100% shares owned by the State), which has been just re-organized, operating under the new law on enterprises. In the past, subject was established as State Owned Enterprise, under the law on State Owned Enterprises.

 

 

PAYMENT HISTORY AND EXPERIENCES

 

Trade Morality

 

Normal

Liquidity

 

Fairly good

Previous Payments

 

Good

Past Trend

 

Developed

Past Financial Situation

 

Good

Current Financial Situation

 

Developed

Legal Action

 

No recorded

Bankruptcy

 

No recorded

Public opinion

 

Good

 

 

FINANCIAL DATA

 

BALANCE SHEET

Unit: Million VND

Balance sheet date

31/12/2005

Number of weeks

52

ASSETS

A. Working assets & short-term Investment

83,950

I. Cash and cash equivalents

2,942

II. Short-term investment

0

 1. Short-term securities investment

0

 2. Other short-term investment

0

 3. Provision for short-term investment

0

III. Receivables

55,022

1. Receivables from customers

21,157

 2. Prepayment for providers

29,361

 3. Value-added tax deducted

4,446

 4. Internal receivables

56

 5. Other receivables

353

 6. Provision for bad receivables

-351

IV. Inventory

25,418

 1. Purchased goods in transit

0

 2. Raw materials

10,643

 3. Instrument, tools

24

 4. Cost for production and business in process

6,508

 5. End products

8,213

 6. Goods

30

 7. Goods on consignment

0

 8. Provision for devaluation of stocks

0

V. Other current assets

568

 1. Advances

451

 2. Prepaid expenses

117

 3. Pending expenses for transfer

0

 4. Pending assets

0

 5. Mortgage, collateral and short run collateral

0

VI. Administrative

0

 1. Administrative expenses for previous year

0

 2. Administrative expenses for current year

0

B. Fixed assets & Long term investment

53,258

I.  Fixed assets

41,864

1. Tangible fixed assets

32,472

   + Original cost

53,259

   + Accumulated depreciation value

-20,787

2.  Financial leasing fixed assets

0

   + Original cost

0

   + Accumulated depreciation value

0

3. Intangible fixed assets

9,392

   + Original cost

9,392

   + Accumulated depreciation value

0

II. Long term investment

5,763

1. Long-term securities investment

0

2. Joint-venture capital contribution

5,763

3. Other long-term investment

0

4. Provision for long-term investment devaluation

0

III. Capital construction in process

5,631

IV. Other

0

TOTAL ASSETS

137,208

LIABILITIES

A. Payable loans

97,497

I. Short term payables

65,399

1. Short-term borrowings

0

2. Due long-term liabilities

0

3. Payables to supplier

56,836

4. Prepayment of buyer

739

5. Taxes and accounts dutiable

3,720

6. Employee payments

4,051

7. Internal payables

0

8. Other payables

53

II. Long term loans

31,000

1. Long-term borrowings

31,000

2. Long-term payables

0

III. Other payables

1,098

1. Payable expenses

1,098

2. Pending assets

0

3. Receipts long-term collateral and deposit

0

B. Owner’s Equity

39,711

I. Capital and Funds

37,346

1. Working capital

29,175

2. Differences from asset revaluation

0

3. Exchange rate differences

0

4. Development investment funds

5,495

5. Reserved funds

2,676

6. Retained profit

0

7. Construction capital sources

0

II. Other administrative and fund sources

2,365

1. Provident funds for unemployment

0

2. Reward and welfare funds

2,365

3. Management funds of higher level

0

4. Functional operation funds

0

5. Fund sources formed by fixed assets

0

TOTAL LIABILITY AND EQUITY

137,208

 

 

PROFIT & LOSE ACCOUNT (INCOME STATEMENT)

 

Description

FY 2005

Total revenue

117,440

Deductions Items

0

- Discount

0

- Devaluation

0

- Return of sold goods

0

- Turnover tax, Luxury tax & Export tax

0

1. Net revenue

117,440

2. Cost of goods sold

103,296

3. Gross Profit

14,144

4. Sales expenses

98

5. Enterprise administrative expenses

5,552

6. Net income from business activities

8,494

Income from financial activities

1,004

Expenditure from financial activities

97

7. Net income from financial operation

907

Irregular income

0

Irregular expenditure

0

8. Irregular Profit

0

9. Total pre-tax profit

9,401

10. Income tax

2,398

11. After tax profit

7,003

 

 

FINANCIAL FACTORS

 

Description

FY 2005

Current Liquidity Ratio

1.28

Quick Liquidity Ratio

0.89

Inventory Circle

4.06

Average Receive Period

171.01

Utilizing Asset Performance

0.86

Liability / Total Asset (%)

71.06

Liability / Owner's Equity (%)

245.52

Income Before Tax / Total Asset (%) ROA

6.85

Income Before Tax / Owner's Equity (%) ROE

23.67

Income Before Tax / Total Revenue (%) NPM

8.00

Gross Profit / Total Revenue (%) GPM

12.04

 

 

INTERPRETATION

 

The subject was a big state owned pharmaceutical manufacturer in the South of Vietnam. It has been changed to be one member liability limited company. The subject has had a long history. After many times of re-organization, the subject now is operating as a liability limited company. The subject has developed quite fast before meeting several difficulties in late 1990s.

 

In the past, the government has supported it by giving a grace soft loan value of 18 billion VND for construction of its new GMP-Asian factory in Tan Binh industry zone. The local government also allows the subject to sell land user right and its old workshop to get the money for this big project. The total factory construction cost up to 52 billion USD that situated in a large area of 14,586 m2.

 

The new factory started operating since 2004. The director has got good support from its clients.

 

The subject situated at large place. It is a rather successful state owned enterprise and the state created many favor conditions for the development of the subject. Management capability is regarded normal and still far behind the requirement. Production and sales are quite large and increasing for years. Profitability is high and staff’s salary is regarded good. Its position in the industry is normal and is improved. Its future seems stable.

           

 

 

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average/normal.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions